These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29096386)

  • 1. Cannabis induced psychosis and subsequent psychiatric disorders.
    Shah D; Chand P; Bandawar M; Benegal V; Murthy P
    Asian J Psychiatr; 2017 Dec; 30():180-184. PubMed ID: 29096386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis-associated psychosis with hypomanic features.
    Rottanburg D; Robins AH; Ben-Arie O; Teggin A; Elk R
    Lancet; 1982 Dec; 2(8312):1364-6. PubMed ID: 6129463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study.
    Kapfhammer HP; Reininghaus EZ; Fitz W; Lange P
    J Clin Psychiatry; 2014 Oct; 75(10):1096-104. PubMed ID: 25373118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.
    Starzer MSK; Nordentoft M; Hjorthøj C
    Am J Psychiatry; 2018 Apr; 175(4):343-350. PubMed ID: 29179576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder: a retrospective evaluation after recurrence.
    Kim JS; Baek JH; Choi JS; Lee D; Kwon JS; Hong KS
    Psychiatry Res; 2011 Jun; 188(1):29-33. PubMed ID: 21056477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study.
    Bergé D; Mané A; Salgado P; Cortizo R; Garnier C; Gomez L; Diez-Aja C; Bulbena A; Pérez V
    Psychiatr Serv; 2016 Feb; 67(2):227-33. PubMed ID: 26467909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M
    Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications.
    Aggarwal M; Banerjee A; Singh SM; Mattoo SK; Basu D
    Asian J Psychiatr; 2012 Sep; 5(3):220-4. PubMed ID: 22981049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
    Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    Andrade C
    J Clin Psychiatry; 2016 Jun; 77(6):e739-42. PubMed ID: 27337422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forty-six cases of psychosis in cannabis abusers.
    Bernhardson G; Gunne LM
    Int J Addict; 1972; 7(1):9-16. PubMed ID: 5043840
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables.
    Trimble MR; Rüsch N; Betts T; Crawford PM
    Seizure; 2000 Jun; 9(4):249-54. PubMed ID: 10880283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course and cognitive outcome in major affective disorder.
    Kessing LV
    Dan Med J; 2015 Nov; 62(11):B5160. PubMed ID: 26522485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cannabis use is associated with severity of Cocaine-Induced Psychosis among cocaine smokers in Martinique, French West Indies.
    Trape S; Charles-Nicolas A; Jehel L; Lacoste J
    J Addict Med; 2014; 8(1):33-9. PubMed ID: 24481081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis Use and the Risk for Psychosis and Affective Disorders.
    Sideli L; Quigley H; La Cascia C; Murray RM
    J Dual Diagn; 2020; 16(1):22-42. PubMed ID: 31647377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.